Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Rheumatoid Arthritis: HELP
Koen Vos
Based on 12 articles published since 2009
(Why 12 articles?)
||||
Expertise Level
The expertise of Koen Vos ranks in the
  • Top 1.1%
  • ... of 82,356 published authors worldwide on Rheumatoid Arthritis
  • ... from 2009 through 2019
  • ... based on contributions to 12 articles on the topic.
Graphical view (beta)
Aliases Vos, Koen   ·   Vos, K
Work Locations
Details
Most likely:    University of Amsterdam      
2015
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. Electronic address: · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of rheumatology, Flevoziekenhuis, Hospitaalweg 1, 1315 RA Almere, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of Rheumatology, Atrium Medical Center, Postbus 4446, 6401 CX Heerlen, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands; GlaxoSmithKline, Stevenage, UK; University of Cambridge, Cambridge, UK; Ghent University, Ghent, Belgium. · Pubmed 26188879
2013
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 23746537
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Pubmed 23620560
2012
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, The Netherlands. · Pubmed 22072013
2011
  • Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 21792840
2010
  • Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 20722020
  • Academic Medical Centre/University of Amsterdam, The Netherlands. · Pubmed 19596693
Probable:    Amsterdam Rheumatology and Immunology Center      
2015
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. Electronic address: · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of rheumatology, Flevoziekenhuis, Hospitaalweg 1, 1315 RA Almere, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of Rheumatology, Atrium Medical Center, Postbus 4446, 6401 CX Heerlen, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands; GlaxoSmithKline, Stevenage, UK; University of Cambridge, Cambridge, UK; Ghent University, Ghent, Belgium. · Pubmed 26188879
2013
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Pubmed 23620560
2012
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, The Netherlands. · Pubmed 22072013
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 12 total) written by Koen Vos about Rheumatoid Arthritis:

  • Intra-articular etanercept treatment in inflammatory arthritis: A randomized double-blind placebo-controlled proof of mechanism clinical trial validating TNF as a potential therapeutic target for local treatment. 2015
  • Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis. 2013
  • Progression of structural damage is not related to rituximab serum levels in rheumatoid arthritis patients. 2013
  • Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. 2012
  • Biological treatment of rheumatoid arthritis: towards a more cost-effective re-treatment regimen using rituximab? 2012
  • Response to rituximab in patients with rheumatoid arthritis in different compartments of the immune system. 2011
  • Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients. 2010
  • Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity. 2010
  • Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis. 2010
  • DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis. 2010
Show List of Full Article Records
Google Searches

Learn more about Koen Vos using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Amsterdam
Amsterdam Rheumatology and Immunology Center
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Amsterdam
2015
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. Electronic address: · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of rheumatology, Flevoziekenhuis, Hospitaalweg 1, 1315 RA Almere, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of Rheumatology, Atrium Medical Center, Postbus 4446, 6401 CX Heerlen, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands; GlaxoSmithKline, Stevenage, UK; University of Cambridge, Cambridge, UK; Ghent University, Ghent, Belgium. · Pubmed 26188879
2013
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 23746537
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Pubmed 23620560
2012
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, The Netherlands. · Pubmed 22072013
2011
  • Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 21792840
2010
  • Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Pubmed 20722020
  • Academic Medical Centre/University of Amsterdam, The Netherlands. · Pubmed 19596693
Amsterdam Rheumatology and Immunology Center
2015
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. Electronic address: · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of rheumatology, Flevoziekenhuis, Hospitaalweg 1, 1315 RA Almere, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands. · Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of Rheumatology, Atrium Medical Center, Postbus 4446, 6401 CX Heerlen, The Netherlands. · Arthrogen B.V., Meibergdreef 45, 1105 BA Amsterdam, The Netherlands; GlaxoSmithKline, Stevenage, UK; University of Cambridge, Cambridge, UK; Ghent University, Ghent, Belgium. · Pubmed 26188879
2013
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Pubmed 23620560
2012
  • Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, The Netherlands. · Pubmed 22072013
3 Other Locations Show
Yearly article counts 00001022142
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.